Finance

Lists
Why is BXP down 2,41%?
Dive Deeper
BXP:LON
Beximco Pharmaceuticals GDR
52,70 GBX
-2,41%
(-1,30) 1D
9 ოქტ, 16:30:00 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for BXP...
Open
50,80 GBX
High
55,00 GBX
Low
50,80 GBX
Avg. vol.
23,15 ათ.
Volume
32,27 ათ.
52-wk high
65,00 GBX
52-wk low
36,70 GBX
Shares outstanding
405,56 მლნ.
No. of employees
1 ათ.
Open
50,80 GBX
High
55,00 GBX
Low
50,80 GBX
Avg. vol.
23,15 ათ.
Volume
32,27 ათ.
52-wk high
65,00 GBX
52-wk low
36,70 GBX
Shares outstanding
405,56 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
About Beximco Pharmaceuticals GDR
CEO-
Employees1,22 ათ.
Founded1976
Headquartersდაკა, Dhaka District, ბანგლადეში
SectorPharmaceutical industry
Websitebeximcopharma.com
Previous reportsAll values in BDT
Loading Previous Earnings...
Revenue
Net income
All values in BDT
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
12,50 მლრდ.
13,79 მლრდ.
14,01 მლრდ.
13,63 მლრდ.
Cost of goods sold
7,17 მლრდ.
7,16 მლრდ.
7,05 მლრდ.
6,93 მლრდ.
Cost of revenue
7,17 მლრდ.
7,16 მლრდ.
7,05 მლრდ.
6,93 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 მლრდ.
3,50 მლრდ.
3,84 მლრდ.
3,84 მლრდ.
Operating expense
3,10 მლრდ.
3,50 მლრდ.
3,84 მლრდ.
3,84 მლრდ.
Total operating expenses
10,27 მლრდ.
10,66 მლრდ.
10,90 მლრდ.
10,77 მლრდ.
Operating income
2,23 მლრდ.
3,14 მლრდ.
3,11 მლრდ.
2,86 მლრდ.
Other non operating income
113,91 მლნ.
129,13 მლნ.
203,65 მლნ.
193,27 მლნ.
EBT including unusual items
2,17 მლრდ.
3,12 მლრდ.
3,12 მლრდ.
2,91 მლრდ.
EBT excluding unusual items
2,13 მლრდ.
3,12 მლრდ.
3,12 მლრდ.
2,91 მლრდ.
Income tax expense
427,45 მლნ.
718,41 მლნ.
732,06 მლნ.
652,35 მლნ.
Effective tax rate
19,74%
23,03%
23,43%
22,44%
Other operating expenses
-
-
-
-
Net income
1,71 მლრდ.
2,36 მლრდ.
2,36 მლრდ.
2,22 მლრდ.
Net profit margin
13,67%
17,13%
16,83%
16,29%
Earnings per share
-
-
-
-
Interest and investment income
27,30 მლნ.
39,60 მლნ.
-
-
Interest expense
-161,48 მლნ.
-186,31 მლნ.
-187,24 მლნ.
-146,06 მლნ.
Net interest expenses
-134,17 მლნ.
-146,71 მლნ.
-187,24 მლნ.
-146,06 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
2,42 მლრდ.
3,62 მლრდ.
3,68 მლრდ.
3,39 მლრდ.
Gain or loss from assets sale
-29,40 მლნ.
111,00 ათ.
-9,16 მლნ.
-4,92 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები